Physician profile

Mark A Freher

Clinical Cardiac Electrophysiology · Delray Beach, FL

NPI 1578576856

$62,187.40

in general payments reported to CMS, 2019-2025

34 companies · $11K in 2025

The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$25,468.22
Travel and Lodging$2,407.71
Consulting Fee$337.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $27,353.04 2019-2025 Aveir, Ensite, Amplatzer Amulet
Acutus Medical, INC. $8,494.31 2020-2023
Elutia, INC. $5,101.39 2019-2025 Ecm Patch,Pouch
Boston Scientific Corporation $5,069.44 2019-2025 Farapulse, General - Crm_crm, Bodyguardian
Cardiofocus, INC. $4,439.64 2019-2024 Heartlight System
Medtronic, INC. $3,662.74 2021-2025 Evera Mri Xt Dr Surescan, Pulseselect, Micra
Biosense Webster, INC. $1,664.91 2020-2025 Carto 3, Nuvision Ice Catheter
Atricure, INC. $1,246.46 2019-2025 Epi-Sense Guided Coagulation System With Visitrax
Cardiva Medical, INC. $790.77 2019-2025 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f
Janssen Pharmaceuticals, INC $717.17 2019-2023 Xarelto
Biotronik INC. $602.91 2019-2025 Biomonitor
Medtronic Vascular, INC. $547.17 2019-2020
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $433.78 2019-2025 Lifevest
Sanofi-Aventis U.S. LLC $382.04 2019-2023
Pfizer INC. $269.20 2019-2025
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Impulse Dynamics (USA) INC. $243.39 2021
Abiomed $149.85 2024-2025 Impella
Philips North America LLC $142.89 2019-2024 (Ao0) Igt Devices Intracardiac, (Am5) Lead Management
Angiodynamics, INC. $142.37 2023 Angiovac, Alphavac
Cvrx, INC. $136.47 2024 Barostim Neo System
Edwards Lifesciences Corporation $113.82 2019
E.R. Squibb & Sons, L.L.C. $96.92 2019-2025 Camzyos, Eliquis
Vital Connect, INC $58.44 2023 Vitalpatch Rtm
Cordis US Corp. $56.55 2024-2025 Mynx Control Venous, Mynx Control
Volta Medical INC $43.80 2023-2024 Vx1
Novartis Pharmaceuticals Corporation $40.60 2020-2021
Terumo Medical Corporation $37.04 2019-2021
Medline Industries LP $33.20 2021-2022
Allergan, INC. $27.64 2022
Coala Life INC $19.55 2020
Braemar Manufacturing, LLC $18.84 2019
Inspire Medical Systems, INC. $18.44 2024 Inspire
Boehringer Ingelheim Pharmaceuticals, INC. $16.65 2021
Kestra Medical Technology Services, INC. $15.97 2025 Assure Wcd

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark A Freher

$62,187.40

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/252264/mark-a-freher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.